Press release: Pfizer and Biontech provide update on Omicron variant Commentaries: Omicron likely to weaken COVID vaccine protection – Nature Pfizer-BioNTech says COVID booster should protect against Omicron – CIDRAP Expert reaction to press release from Pfizer-BioNTech about omicron and neutralising antibody titres after two and three vaccine doses – Science Media Centre Covid: Pfizer […]

The post [Press release – not published yet] Lab study suggests a third dose (booster) of the Pfizer–BioNTech vaccine may be necessary to provide an adequate immune response to the Omicron variant. appeared first on Links Medicus.